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Introduction {#sec1}
============

Hematopoietic stem cells (HSCs) arise through a developmental fate process known as endothelial-to-hematopoietic transition (EHT) ([@bib17], [@bib18], [@bib28]). EHT is best characterized by the emergence of intra-aortic hematopoietic cluster (IAHC) cells within the aorta-gonad-mesonephros (AGM) region that transdifferentiate from specialized hemogenic endothelial cells ([@bib15], [@bib49], [@bib79], [@bib81]). Between mouse embryonic day (E)10.5 and E12.5, IAHCs contain HSCs, hematopoietic progenitor cells (HPCs), and other hematopoietic cells (HCs). Time-lapse imaging gave the first visual *in vivo* proof of EHT in the mouse and zebrafish embryonic aorta ([@bib5], [@bib7], [@bib31]). This transition involves changes from an endothelial transcriptional program to a program promoting HC identity, morphology, and function ([@bib68]). Although the precise program directing the generation of HSCs during EHT is as yet unknown, important molecular and physiological aspects of HSC generation are conserved between zebrafish, chick, *Xenopus*, mouse, and human ([@bib13], [@bib17], [@bib27]).

Quantitation of IAHC cells in whole mouse embryos ([@bib79]) shows a peak of \~700 phenotypic (cKit-positive) HCs at E10.5. Multicolor lineage tracing shows that clusters are polyclonal, with about 545 Vav^+^ nascent hematopoietic progenitor/stem cells (HP/SCs) emerging between E11.5 and 14.5 to establish lifelong hematopoiesis ([@bib22]). However, in the E10.5 aorta at the time of embryo isolation, very few of these cells function as bona fide HSCs ([@bib33], [@bib43], [@bib48]), as determined by direct *in vivo* transplantation and long-term hematopoietic reconstitution of adult recipients (a standard test for HSC function and clinical relevance). Recent *in vivo* marking methods question the precise role of phenotypic HSCs defined by *in vivo* repopulating activity and, instead, suggest that multipotent progenitors are responsible for adult steady-state hematopoiesis ([@bib10], [@bib53], [@bib59], [@bib63], [@bib67]). Out of the hundreds of IAHC cells in E10.5 embryos, colony-forming unit-culture (CFU-C) studies show that about half (350) of the cluster cells are HPCs ([@bib16]). Thus, the very low frequency of HSCs in the IAHCs highlights the complexity in programming HSC identity as defined by repopulating function and raises the questions: what processes influence acquisition of this rare HSC identity rather than the more abundant HPC or HC identities, and can we capture the transcriptome of the first HSCs?

Many studies, including our own, have set out to describe the genetic program of HC transdifferentiation from that of embryonic aortic endothelium. Published transcriptome databases are available for phenotypically (surface marker) enriched endothelial cells, hemogenic endothelial cells, transitioning cells, IAHCs, and HP/SCs, at both the population and single-cell levels ([@bib3], [@bib35], [@bib36], [@bib37], [@bib42], [@bib47], [@bib64], [@bib68], [@bib80]). However, no unique transcriptional profile has yet been ascribed to AGM HSCs, since the HSC transcriptome is represented in the single-cell datasets only at a very low frequency compared with the high frequency of HPCs and HCs. Interestingly, all these datasets show the upregulated expression of several hematopoietic ("heptad") transcription factors (TFs) ([@bib76]) during EHT, including *Gata2*, which is pivotal to HSC and HPC generation.

*Gata2* is required for generation of IAHCs and functional HSCs ([@bib16], [@bib38], [@bib72], [@bib71]). Haploinsufficiency perturbs EHT and the timing and quantitative generation of HSCs ([@bib16], [@bib38]), and its overexpression blocks HSC function ([@bib23], [@bib70]). Our recent demonstration of pulsatile Gata2 expression level changes in aortic endothelial cells undergoing EHT ([@bib19]) reveals a previously unexplored dynamic regulatory aspect in hematopoietic fate acquisition. Studies in other systems have shown an unstable program of gene expression in cells as they take on specific lineage fate. These include regulators nuclear factor κB (NF-κB), Hes, and Nanog, which show pulsatile expression behavior in single cells ([@bib1], [@bib11], [@bib14], [@bib26], [@bib32], [@bib34], [@bib46], [@bib58], [@bib61]).

To date, transcriptomic analyses of HSCs have relied on cell-surface-marker-mediated enrichments. As TFs are responsible for promoting the expression of these markers, hematopoietic identities may be better understood through direct enrichment based on TF expression. Our previously described *Gata2Venus* (*G2V*) mouse model reports real-time transcription and protein expression of Gata2 *in vivo* without affecting hematopoietic development or function ([@bib29]). To understand whether the transcriptome of single IAHC cells ([@bib3], [@bib80]) correlates with hematopoietic function, and whether HSC identity is based on specific combinations of genes and expression levels, *G2V* embryos were used to examine IAHC cells by iterative single-cell transcriptomics and functional analyses. Here, we show that functional heterogeneity in highly enriched single index-sorted IAHC cells expressing medium levels of Gata2 (G2^med^) corresponds with heterogeneity in TF expression levels. Following this, we reveal that specific expression levels of Gata2, cKit, and CD27 define all *in vivo* repopulating HSCs and that HSCs localize to IAHCs containing 1--2 cells. This iterative methodology captures the transcriptome of the first functional HSCs and closely related HPCs and suggests a stochastic process of quantitative molecular states leading to the establishment of HSC identity.

Results {#sec2}
=======

Specific Gata2 and cKit Levels Define All HSCs and the Majority of Multipotent HPCs {#sec2.1}
-----------------------------------------------------------------------------------

Previously, we showed that Venus fluorescence faithfully reports Gata2 expression in *Gata2IRESVenus* reporter (*G2V*) mice ([@bib19], [@bib29]). In *G2V* embryos, the spatiotemporal expression of Gata2 and the development of EHT and HSC are normal. At E10.5, all HSCs and 70% of HPCs express G2^med^. Some HPCs are Gata2 negative (G2^−^) or high (G2^hi^) ([@bib19], [@bib29]), and mature mast cells express the highest levels ([@bib30], [@bib71]). To focus on the most potent Gata2-expressing progenitors and HSCs, we followed a multi-pronged approach combining the refinement of sorting gates and single-cell index-sorting with functional *in vivo* and *in vitro* assays. G2^med^CD31^+^ckit^+^ IAHC cells (all IAHC cells co-express CD31 and cKit) were separated into low (G2^lo^) and intermediate (G2^int^) Gata2 fractions and further partitioned into cKit^lo^ and cKit^hi^ fractions ([Figure 1](#fig1){ref-type="fig"}A). *In vitro* progenitor assays ([Figure 1](#fig1){ref-type="fig"}B) of the four fractions revealed that most HPCs were distributed equally between the CD31^+^cKit^hi^G2^lo^ and -G2^int^ fractions at both E10 and E11. Whereas, at E10, few or no CFU-Cs were found in the cKit^lo^ fractions, these fractions at E11 contained some CFU-Cs. Multipotent CFU-GEMMs (colony forming unit-granulocyte-erythroid-macrophage-megakaryocytes) were highly enriched or exclusively found in the CD31^+^cKit^hi^G2^lo^ and -G2^int^ fractions (the latter containing slightly more GEMMs) at both embryonic stages.Figure 1The Most Immature AGM HPCs Are cKit^hi^CD31^hi^(A) Flow-cytometric dot plots of representative E11 *G2V* AGM cells analyzed for side scatter (SSC-A) and CD31 expression (left) and cKit and Gata2 (G2) expression of CD31^+^ cells (right). Cell percentage (±SEM) within gated regions. Hi, high; lo, low; int, intermediate; med, medium (lo+int).(B) Hematopoietic progenitor numbers per lineage per embryo equivalent (ee) of E10 (32--37 somite pairs, sp; n = 4; embryos/experiment: 4, 4, 4, and 4) and E11 (43--48 sp; n = 3; embryos/experiment: 3, 6, 5, and 7) sorted AGM fractions in the colony-forming unit-culture (CFU-C) assay. GEMM, granulocyte-erythroid-macrophage-megakaryocyte; GM, granulocyte-macrophage; M, macrophage; G, granulocyte; BFU-E, burst-forming unit-erythroid. Error bars represent mean ± SEM. For E10 GEMMs: ^∗^cKit^hi^G2^int^ versus cKit^lo^G2^lo/int^. For E11 GEMMs: ^∗^cKit^hi^G2^lo^ versus cKit^lo^G2^lo/int^, and ^∗∗^cKit^hi^G2^int^ versus cKit^lo^G2^lo/int^. For E11 GMs: ^∗^cKit^hi^G2^int^ versus cKit^lo^G2^lo/int^.(C and D) E11 *G2V* AGM single cells were sorted for (C) CD31^+^cKit^hi^G2^int^ (11 embryos, 41--47 sp) and (D) CD31^+^cKit^+^G2^hi^ cells (20 embryos; 40--49 sp) and deposited in methylcellulose. CFU-Cs were counted at days 9--11 (total CD31^+^cKit^hi^G2^int^ = 169; total CD31^+^cKit^+^G2^hi^ = 105). Each CFU (individual dot) was examined for colony type and plotted against log~10~-normalized mean fluorescence intensities (MFIs) for expression of (Ci and Di) G2, (Cii and Dii) cKit, and (Ciii and Diii) CD31. Red lines indicate mean ± SEM.(E) HSC activity in sorted AGM fractions as measured by *in vivo* transplantation (peripheral blood donor chimerism at 4 months post-injection). Cell numbers injected: for cKit^hi^G2^lo^, 950--1963, 2.9--5.4 ee; for cKit^hi^G2^int^, 912--2,048, 2.5--6.2 ee; for cKit^lo^G2^med^, 4,530--12,523, 3.3--5.9 ee (42--50 sp; n = 4; embryos/experiment: 7, 9, 12, and 14).

Index-sorted CD31^+^cKit^hi^G2^int^ (G2^int^) cells ([Figures 1](#fig1){ref-type="fig"}B and 1C) and CD31^+^cKit^+^G2^hi^ (G2^hi^) cells (as control; [Figure 1](#fig1){ref-type="fig"}D) were examined in single-cell CFU assays to test whether HPC lineage potential was related to Gata2 level. After 9--11 days, both G2^int^ and G2^hi^ cells produced CFU-GEMMs, -GMs (granulocyte-macrophages), -Gs (granulocytes), and -Ms (macrophages) ([Figures 1](#fig1){ref-type="fig"}Ci and 1Di; plating efficiency, 1:5--6 and 1:2--4, respectively). However, the proportion of GEMMs was higher in the G2^int^ fraction (22% versus 9%). The CFU-C type arising from each single index-sorted cell was plotted against log-normalized mean fluorescent intensities (MFIs) for G2 ([Figures 1](#fig1){ref-type="fig"}Ci and 1Di), cKit ([Figures 1](#fig1){ref-type="fig"}Cii and 1Dii), and CD31 ([Figures 1](#fig1){ref-type="fig"}Ciii and 1Diii). Cells that produced CFU-GMs and -Gs were widely varying in levels of G2 expression (MFI = 842--8,315) compared to those that produced CFU-GEMMs and -Ms (MFI = 850--4,845). The average MFI for cKit expression on G2^int^ cells yielding CFU-GEMMs was significantly higher than for cells yielding CFU-Gs ([Figure 1](#fig1){ref-type="fig"}Cii), and the average MFI for cKit expression on G2^hi^ cells yielding CFU-GEMMs was significantly higher than for the other three CFU types ([Figure 1](#fig1){ref-type="fig"}Dii). Both G2^int^ and G2^hi^ fractions contained cells yielding CFU-GEMMs with a significantly higher average CD31 MFI than that for cells yielding CFU-Gs ([Figures 1](#fig1){ref-type="fig"}Ciii and 1Diii). Thus, the most immature HPCs are cKit^hi^ and CD31^hi^.

Examination of *in vivo* repopulating activity within the sorted E11 IAHC fractions showed that, despite G2^int^ containing slightly more (multipotent) HPCs, both CD31^+^cKit^hi^G2^lo^ and -G2^int^ cells provided HSC engraftment at 4 months post-transplantation ([Figure 1](#fig1){ref-type="fig"}E). No HSCs were detected in the CD31^+^cKit^lo^G2^med^ fraction ([Figure 1](#fig1){ref-type="fig"}E) or, as we previously reported, in the G2^hi^ fraction ([@bib19]).

Transcriptome Heterogeneity and Clustering of Single CD31^+^cKit^hi^G2^med^ Cells {#sec2.2}
---------------------------------------------------------------------------------

Considering that, at E11, all GEMMs were found in the G2^lo^, G^int^, and G2^hi^ fractions and that HSCs are exclusively in the G2^lo^ and G2^int^ fractions, we index-sorted CD31^+^cKit^hi^G2^med^ (G2^lo^+G2^int^ = G2^med^) IAHC cells and analyzed them by single-cell RNA sequencing (RNA-seq) using SmartSeq2 ([@bib55]). Out of 1,015 CD31^+^cKit^hi^G2^med^ cells, 968 passed quality control (95%). Of note, the mapping of reads was performed using a custom reference that included the mouse genome, the sequence of *Venus* and External RNA Controls Consortium (ERCC) sequences, allowing confirmation of the co-regulation of *Gata2* and *Venus* expression levels ([Figure S1](#mmc1){ref-type="supplementary-material"}A; correlation coefficient, 0.7). We obtained the SPRING visualization ([@bib75]) of the 968 cells and defined 11 clusters (L1.1--L1.11) using the Louvain method ([Figure 2](#fig2){ref-type="fig"}A; [Figure S1](#mmc1){ref-type="supplementary-material"}Bi). Datasets obtained from several biological samples, or analyzed on different days, integrated well and showed no batch effect ([Figure S1](#mmc1){ref-type="supplementary-material"}Bii). Hence, cell acquisition parameters and results were consistent between experiments.Figure 2Five Distinct Transcriptomic Clusters Are Defined by Single-Cell RNA Sequencing of Highly Enriched AGM HSCs(A) SPRING visualization of merged Louvain clusters corresponding to 968 single CD31^+^cKit^hi^G2^med^ IAHC cells (n = 6 at E11, 27.6 *G2V* embryos, 41--49 somite pairs; n = 1 at E10, 2.7 *G2V* embryos, 33--34 sp). See [Figure S1](#mmc1){ref-type="supplementary-material"}B for Louvain clustering. Five clusters emerge based on the cell-lineage expression characteristics and hierarchical clustering distances. EC, endothelial-like cluster; HC1, hematopoietic cluster 1; HC2, hematopoietic cluster 2; UC1, unknown cluster 1; UC2, unknown cluster 2.(B--D) Cells were colored according to the expression of (B) hematopoietic markers, (C) endothelial markers, and (D) hematopoietic \"heptad\" transcription factors.(E) Heatmap and hierarchical clustering of the dataset of 968 CD31^+^cKit^hi^G2^med^ index-sorted cells using endothelial-, pre-HSC-, and HSC-specific genes (indicated on the left in red, blue, and green, respectively) obtained from a published dataset of phenotypically enriched endothelial cells, pre-HSCs (T1+T2), and E12/E14 HSCs ([@bib80]). Louvain identity (L1.1 to L1.11) and merged clusters (EC, HC1, HC2, UC1, and UC2) are also indicated (top).

To investigate cluster composition, cells were colored according to the expression of well-known hematopoietic ([Figure 2](#fig2){ref-type="fig"}B) and endothelial ([Figure 2](#fig2){ref-type="fig"}C) genes as well as several pivotal hematopoietic TFs (heptad TFs; [Figure 2](#fig2){ref-type="fig"}D). In this way, we could merge clusters to define 5 main groups of cells within our highly enriched HSC population ([Figure 2](#fig2){ref-type="fig"}A). The endothelial-like cluster (EC; L1.1 and L1.2) contained 335 cells expressing endothelial genes such as *Flk1* (*VEGFR-2*), *Cdh5* (*VE-cadherin*), and *AplnR*. *Runx1*, which would be expected to be expressed in all cells ([@bib4]), was downregulated in the EC when compared to the other clusters. The hematopoietic cluster (HC) contained 529 cells (L1.7--L1.11) expressing well-known hematopoietic marker genes such as *CD41*, *CD45*, *PU.1*, and *Gpr56*. HCs could be subdivided into HC1 (405 cells; L1.7 and L1.8) and HC2 (124 cells; L1.9--L1.11) cells, according to the expression of genes such as *VE-cadherin* and *Ly6a*. Finally, two smaller unknown clusters were defined: UC1 and UC2. UC1 contained 85 cells (L1.5--L1.6) expressing some hematopoietic markers such as *CD45* and *PU.1* and lacking expression of *CD41*, *Gpr56*, and endothelial markers *Flk1*, *Cdh5*, and *AplnR*. Cells within this cluster also expressed high levels of *Runx1*. UC2 contained 19 cells (L1.3--L1.4) that expressed *Gata2* consistently, although there were too few cells for confident analysis. In a more detailed analysis of the expression of the heptad TFs, *Gata2* showed some heterogeneity in expression levels in all clusters except UC1, in which it was downregulated (see [Discussion](#sec3){ref-type="sec"}). *Tal1* also showed heterogeneous expression in all clusters. *Erg* and *Lmo2* were downregulated in HC2. These data demonstrate heterogeneity in heptad TF expression among the single cells of highly enriched HPCs and HSCs. While some cell clusters show consistent levels of one TF, other TFs vary in expression within a cluster, suggesting an unstable regulation and/or dynamic expression between highly similar single cells.

We also calculated the similarity of each cell to the gene expression profile of validated adult bone marrow HSCs using hscScore ([@bib24]) ([Figure S1](#mmc1){ref-type="supplementary-material"}C). The cells within HC1 obtained the highest score, suggesting that this cluster most likely contains the HSC fraction. Our datasets were further examined in the context of a published single-cell dataset ([@bib80]) of phenotypically enriched AGM endothelial cells, pre-HSCs (type 1 and type 2), and E12 and E14 fetal liver HSCs. First, 3 groups of genes specifically expressed in endothelial cells, pre-HSCs, and HSCs were defined by comparing the different cell types represented in the published dataset ([Figure S1](#mmc1){ref-type="supplementary-material"}D). These genes were used to cluster our dataset ([Figure 2](#fig2){ref-type="fig"}E). Our EC correlated well with the endothelial profile. HC1 contained cells that expressed both pre-HSC-specific genes (*Procr*) and HSC-specific genes (*CD41, Mpl*, and *Ly6a*) (mainly cells within L1.7) and cells that expressed predominantly only HSC-specific genes (mainly cells within L1.8). HC2 represented a more mature hematopoietic profile where cells expressed all HSC-specific and no pre-HSC-specific genes. UC1 had some endothelial and hematopoietic features and expressed mature hematopoietic genes, including *Cd53*, *Cd84*/SLAM, *Mndal*/myeloid, and *Sp100/PML*; almost no pre-HSC-specific genes; and a subset of endothelial-specific genes (*Pmp22*, *Anxa2*, *Anxa3*, *Ophn1*, *Marcks*, and *Tcf4*).

Phenotypic Characteristics Derived from Index-Sorting Guide Further Enrichment of Multipotent HCs {#sec2.3}
-------------------------------------------------------------------------------------------------

To examine whether the 5 transcriptomic clusters of CD31^+^cKit^hi^G2^med^ cells correspond to specific hematopoietic activities, index-sorting data were analyzed for phenotypic characteristics that would provide for cluster-distinct cell isolation. EC cells were CD31^hi^ and side-scatter high (SSC^hi^), UC1+UC2+HC2 cells were CD31^lo^, and HC1 cells were CD31^hi^ and SSC^lo^ ([Figure 3](#fig3){ref-type="fig"}A). No clear further separation was observed within the cKit^hi^ fraction ([Figure 3](#fig3){ref-type="fig"}B), although HC1 cells expressed higher levels of cKit than EC and UC1+UC2+HC2 cells, which showed variable levels. Based on these new sorting parameters (CD31^hi^SSC^hi^, CD31^lo^, and CD31^hi^SSC^lo^), three fractions were sorted and tested *in vitro* for CFU-C formation and *in vivo* for long-term HSC repopulation.Figure 3Index-Sorting Parameters Separate Transcriptomic Clusters and Guide Further Enrichment of Functional Hematopoietic Stem and Multipotent Progenitor Cells(A and B) Flow-cytometric plots showing (A) side-scatter (SSC-A) and CD31 expression and (B) cKit and Gata2 (G2) expression of the 968 index-sorted single cells. The color of each cell indicates presence in specific clusters: EC (endothelial-like cluster, green), HC1 (hematopoietic cluster 1, blue), HC2 (hematopoietic cluster 2, ochre), UC1 (unkown cluster 1, magenta), and UC2 (unkown cluster 2, rose).(C) Hematopoietic progenitor number and type per embryo equivalent (ee) of bulk-sorted E11 IAHC cells (n = 4; 41--50 somite pairs, sp; embryos/experiment: 8, 8, 3, 8) corresponding to transcriptomic clusters, as determined by colony-forming unit-culture (CFU-C) assay. GEMM, granulocyte-erythroid-macrophage-megakaryocyte; GM, granulocyte-macrophage; M, macrophage; G, granulocyte; BFU-E, burst-forming unit-erythroid. For GEMMs: ^∗^EC versus HC1; for GMs: ^∗^EC versus HC1, and ^∗∗^UC1+2+HC2 versus EC. Mean ± SEM.(D) HSC activity in sorted E11 IAHC cells (n = 5; 40--49 sp; embryos/experiment: 15, 14, 11, 8, and 19) corresponding to transcriptomic clusters by *in vivo* transplantation. Each point indicates percentage of donor-derived cells in peripheral blood of recipients at 4 months post-injection. Cell numbers injected: for HC1, 721--2,811, 4.8--8 ee; for EC, 5,654--14,208, 4.7--8.1 ee; for UC1+2+HC2, 1,312--2,828, 4.8--8.4 ee. Black line indicates mean.(E) In (Ei), cytometric gates were used for sorting HC1 cells from E11 *G2V* IAHCs (16.7 embryos, 41--49 sp). Single cells deposited for CFU-Cs were counted at 12 days (total CFU-Cs = 86). Each CFU (individual dot) was examined for colony type and plotted against log~10~-normalized mean fluorescence intensities (MFIs) for (Eii) G2, (Eiii) cKit, and (Eiv) CD31 expression. GEMM, granulocyte-erythroid-macrophage-megakaryocyte; GM, granulocyte-macrophage; G, granulocyte; M, macrophage. Red lines indicate mean ± SEM.

No CFU-Cs were generated from EC cells (CD31^hi^SSC^hi^; [Figure 3](#fig3){ref-type="fig"}C) as expected. CD31^lo^cKit^hi^G2^med^ cells (UC1+UC2+HC2) contained 50 CFU-Cs per embryo equivalent (ee) of various CFU-C types. CD31^hi^SSC^lo^cKit^hi^G2^med^ cells (HC1) contained 30 CFU-Cs per ee. Interestingly, a trend of more multipotent HPCs (7 GEMMs per ee), fewer bi-potent HPCs (17 GMs per ee), and few or no unipotent HPCs (Gs and burst-forming unit-erythroid \[BFU-Es\]) was detected in HC1 cells as compared to the UC1+UC2+HC2 cells (5 GEMMs per ee and 24.5 GMs per ee). The results of long-term *in vivo* transplantations showed that the HC1 fraction contains all HSCs ([Figure 3](#fig3){ref-type="fig"}D) and is 10.5-fold enriched compared to the CD31^+^cKit^+^G2^med^ fraction.

To provide scope for further enrichment of HSCs and multipotent HPCs, HC1 cells ([Figure 3](#fig3){ref-type="fig"}Ei) were index-sorted and analyzed for single-cell CFU-C lineage output and G2, cKit, and CD31 MFIs. A total of 86 CFU-Cs was obtained (plating efficiency, 1:9--11). Ninety-two percent (21% GEMMs + 71% GMs) of the CFU-Cs were multipotent/bipotent ([Figure 3](#fig3){ref-type="fig"}Eii). Cells yielding GEMMs showed significantly higher average MFIs for G2 expression as compared to GM and G cells ([Figure 3](#fig3){ref-type="fig"}Eii). MFIs for cKit ([Figure 3](#fig3){ref-type="fig"}Eiii) and CD31 ([Figure 3](#fig3){ref-type="fig"}Eiv) were not significantly different when GEMM and GM cells were compared. Together, these data indicate that all HSCs and the most multipotent HPCs are enriched within the CD31^hi^SSC^lo^cKit^hi^G2^med^ (HC1) fraction and that cells that produce GEMMs had higher G2 MFIs as compared to the more widely varying G2 MFIs for GM-producing cells.

Iterative Analyses Link Expression of Specific Genes with HSC and Multipotent HPC Function {#sec2.4}
------------------------------------------------------------------------------------------

Gene lists were examined for new candidate markers of HC1 cells as compared to the other clusters ([Table S1](#mmc2){ref-type="supplementary-material"}). Violin plots showed significantly higher *Tnfrsf7* (CD27) expression in HC1 ([Figure 4](#fig4){ref-type="fig"}A; [Figure S2](#mmc1){ref-type="supplementary-material"}A), as well as *Selp* and *Mpl* ([Figure S2](#mmc1){ref-type="supplementary-material"}B). Index-sorting parameters revealed that 70% of E11 CD31^hi^SSC^lo^cKit^hi^G2^med^ (HC1) cells were CD27^+^ ([Figure 4](#fig4){ref-type="fig"}B). Using this wide (+W) gate (MFI = 150--7,000), CD27^+W^ cells were isolated and transplanted into irradiated recipients. High-level, long-term multilineage *in vivo* repopulation by the CD27^+W^ HC1 donor cells was detected in 2 of 2 recipients ([Figure 4](#fig4){ref-type="fig"}C, open squares). Secondary transplantations confirmed that these were self-renewing HSCs ([Figure S3](#mmc1){ref-type="supplementary-material"}A). For further enrichment, a higher and narrower (+N) CD27 gate (MFI = 500--7,000) was set ([Figure 4](#fig4){ref-type="fig"}B), and CD27^+N^ (19%) and CD27^−/lo^ (81%) HC1 cells were transplanted. The CD27^+N^ HC1 cells yielded high-level, long-term multilineage repopulation in both primary ([Figure 4](#fig4){ref-type="fig"}C, black squares) and secondary ([Figure S3](#mmc1){ref-type="supplementary-material"}A) transplantations. No HSCs were found in the CD27^−/lo^ HC1 fraction, even with injection of high numbers of cells. As compared to the CD31^hi^SSC^lo^cKit^hi^Gata2^med^ sorted fraction, the CD27^+N^ gate enriches HSCs by a further 5.2-fold.Figure 4All Functional AGM HSCs Are within the HC1 CD27^med^ Fraction(A) Violin plots of *Tnfrsf7* (CD27) expression in the 5 major transcriptomic clusters. EC, endothelial-like cluster; HC1, hematopoietic cluster 1; HC2, hematopoietic cluster 2; UC1, unknown cluster 1; UC2, unknown cluster 2.(B) Enrichment sorting parameters for CD27^+^ HC1 cell isolation. Side scatter (SSC-A), CD31, cKit, Gata2 (G2), and CD27 sorting gates and percentage (±SEM) of cells. CD27^+^ cells (%) are indicated within a wide (+W) and a narrow (+N) mean fluorescent intensity (MFI) gate.(C) Analysis of HSC function within CD27 fractions (CD27^+W^, CD27^+N^, and CD27^−/lo^) of HC1 cells by *in vivo* transplantation. Open squares denote CD27^+W^ HC1 cell recipients (n = 2) of 442 cells (2.5ee) and 479 cells (3.3 ee) from 15 and 9 (42--50 somite pairs, sp) embryos, respectively. Closed squares (n = 4; 42--49 sp; embryos/experiment: 25, 11, 22, 28) denote recipients injected with CD27^+N^ HC1 cells (238--957; 3.7--9.8 ee), EC cells (899--2,333; 3.9--8.6 ee), CD27^-/lo^ HC1 cells (1,042--4,325; 4.1-9.8 ee), and UC1+2+HC2 cells (1,361--3,741; 4.2--9.9 ee). Percentage of donor cell chimerism in peripheral blood of recipients at 4 months post-injection. Black line indicates mean.(D) Single-cell RNA-seq of 119 CD31^hi^SSC^lo^cKit^hi^Gata2^med^CD27^+N^ sorted cells (all passed quality control) from 6 embryos (41--47 sp). These data combined with the previous dataset (gray) resulted in an extended dataset SPRING plot of 1,087 cells in total. Overlay of CD27^+N^ cells (red) showing localization to one HC1 subcluster (circled).(E) Single CD27^+N^ HC1 cells from E11 *G2V* IAHCs (50 embryos; 42--49 sp) deposited into methylcellulose and colony-forming unit-culture (CFU-C) counts at 8--10 days (138 total CFU-Cs). Colony type (individual dot) plotted against log~10~-normalized mean fluorescence intensities (MFIs) for (Ei) CD27, (Eii) G2, (Eiii) cKit, and (Eiv) CD31 expression. GEMM, granulocyte-erythroid-macrophage-megakaryocyte; GM, granulocyte-macrophage. Red lines indicate mean ± SEM.(F) Representative FACS plot showing newly defined CD27^med^ MFI range (red dotted line) within the CD27^+N^ fraction. Percentage ±SEM.(G) Summary of enrichment strategy. The HC1 fraction containing all HSCs is 10.5-fold enriched compared to previous sorting strategies ([@bib19]). Further enrichments are based on gating of specific CD27^+N^ and CD27^med^ fractions to give an additional 6.5-fold enrichment. After iterative analyses and refinement of sorting gates, a total combined HSC enrichment of 68.3-fold is achieved.

Single-cell RNA-seq of 119 CD31^hi^SSC^lo^cKit^hi^Gata2^med^CD27^+N^ cells (from 6 AGMs) was performed, and data were combined with the 968 cells to produce a new SPRING plot of 1,087 cells. Louvain clustering showed a cluster distribution (L2.1--L2.12) of the 1,087 cells ([Figures S3](#mmc1){ref-type="supplementary-material"}B and S3C) almost identical to that obtained from the 968 cells ([Figure S1](#mmc1){ref-type="supplementary-material"}Bi). The majority (71%) of the 119 CD27^+N^ cells ([Figure 4](#fig4){ref-type="fig"}D, red) localized to HC1, and 58% localized to L2.8 ([Figure 4](#fig4){ref-type="fig"}D, circled).

Interestingly, when index-sorted CD27^+N^ cells were analyzed in single-cell CFU-C assays (plating efficiency, 1:3--4 cells), GEMM-forming cells showed a significantly lower average CD27 MFI (767.1 ± 41.8; [Figure 4](#fig4){ref-type="fig"}Ei) and a significantly higher G2 MFI (1,022.0 ± 60.1; [Figure 4](#fig4){ref-type="fig"}Eii) than those of GM-forming cells (945.2 ± 44.6 and 858.3 ± 31.8, respectively). Average cKit and CD31 MFIs were not significantly different ([Figures 4](#fig4){ref-type="fig"}Eiii and 4Eiv). Notably, 95% of immature/HSC-like progenitors forming GEMMs fall within the smaller CD27 MFI range of 513--1,084 ([Figure 4](#fig4){ref-type="fig"}F, red dotted area), which is now referred to as CD27^med^. The CD27^med^ fraction is 15.5% ± 1.3% of HC1 and 86% of CD27^+N^ cells. There are 20 ± 2 CD27^med^ HC1 cells per AGM, of which 1--2 were HSCs at the time of analysis. In addition to our HC1 enrichment (10.5-fold), a further 6.5-fold enrichment of HSCs was achieved in the CD27^med^ fraction to yield a combined enrichment of 68.3-fold (summarized in [Figure 4](#fig4){ref-type="fig"}G).

Defining the AGM HSC Transcriptome {#sec2.5}
----------------------------------

The increased enrichment of multipotent cells within the CD27^med^ MFI range provided a means for dataset refinement in which the molecular profiles of different functional subsets could be examined. Out of the 119 CD31^hi^SSC^lo^cKit^hi^Gata2^med^CD27^+N^ cells previously isolated for single-cell RNA-seq ([Figure 4](#fig4){ref-type="fig"}D), 85 belonged to HC1, of which 14 showed CD27^hi^ and 71 CD27^med^ expression. We analyzed the 85 cells using Iterative Clustering and Guide-gene Selection (ICGS) ([@bib51]), which can define groups of genes that behave similarly and identify groups of cells with similar gene-expression patterns. Three groups of genes and 3 groups of cells that we named ICGS1, ICGS2, and ICGS3 contained 54, 29, and 2 cells, respectively ([Figures S4](#mmc1){ref-type="supplementary-material"} and [S5](#mmc1){ref-type="supplementary-material"}). When the distribution of the ICGS groups within the previously defined L2.7 and L2.8 clusters was examined, 81% of the 85 CD27^+N^ cells fell within L2.8, and 19% fell within L2.7. ICGS1 cells were mainly in L2.8, whereas ICGS2 cells were equally distributed in L2.7 and L2.8, suggesting that these cells are acquiring HSC identity. The hscScore for each cell was calculated and plotted against its CD27 MFI value ([Figure 5](#fig5){ref-type="fig"}A). ICGS2 cells were almost exclusively in the CD27^med^ and high hscScore range, whereas ICGS1 cells were within the full CD27 MFI range and showed a low hscScore. Together, these data confirm that ICGS2 cells are the most multipotent or HSC-like.Figure 5Defining the Transcriptome of the First Functional HSCs(A) Plot of hscScore against CD27 MFI for 85 CD31^hi^SSC^lo^cKit^hi^Gata2^med^CD27^+N^ cells. Majority of ICGS2 cells (black) found in the CD27^med^ and higher hscScore range and ICGS1 cells (red) within the full CD27 MFI and mostly low hscScore range. ICGS3 cells are indicated in gray.(B) *Ly6a* expression was plotted on the SPRING visualization of (Bi) 85 CD31^hi^SSC^lo^cKit^hi^Gata2^med^CD27^+N^ cells, (Bii) 71 CD27^med^ cells (CD27^hi^ in green), and (Biii) 14 CD27^hi^ cells (CD27^med^ in green) within HC1 (gray).(C) Replotting of 85-cell heatmap in [Figure S4](#mmc1){ref-type="supplementary-material"} (maintaining the same order and position) with subset of ICGS output ([Figure S5](#mmc1){ref-type="supplementary-material"}) for the 23 *Ly6a*^+^CD27^med^ cells belonging to HC1 (L2.7+L2.8). 3 gene clusters (RowCluster) and 2 cell clusters (ICGS1 and ICGS2) can be defined. HscScore, log~10~ of the CD27 index-sorting (protein) levels and Louvain identity (L2.7, L2.8) are also depicted.

To more precisely identify the transcriptome of the few HSCs within the 85 cell profiles, other known HSC characteristics were examined. *Ly6a* is known to be expressed by all *in vivo* adult repopulating AGM HSCs ([@bib15]). *Ly6a* can be detected in 27 of the 85 cells within HC1 ([Figure 5](#fig5){ref-type="fig"}Bi), 23 of 71 CD27^med^ cells ([Figure 5](#fig5){ref-type="fig"}Bii), and 4 of 14 CD27^hi^ cells ([Figure 5](#fig5){ref-type="fig"}Biii), consistent with previous findings that *Ly6a* expression is not exclusive to HSCs. We then focused our attention on the 23 *Ly6a*^+^ cells within the "multipotent/HSC" CD27^med^ MFI range ([Figure 5](#fig5){ref-type="fig"}C). These cells separated into two ICGSs: 15 belonged to ICGS1, and 8 belonged to ICGS2. The 8 cells contained in ICGS2 had the highest hscScores: 4 belonged to L2.7, and 4 belonged to L2.8. Thus, the stratified results of single-cell index-sorting, transcriptome profiling, and functional analyses strongly suggest a profile for HSCs that is unique but closely related to that of multipotent HPCs.

Considering the expression of several genes relevant to HSC generation, the profile for the 8 *Ly6a*^+^CD27^med^ ICGS2 single cells stands out ([Figure 5](#fig5){ref-type="fig"}C). Notch pathway genes ([@bib6]) are highly represented in these cells and include *Hes1* and *Hey1* (negative regulators), *Dll4* (Notch ligand), and *Notch4*. *Sox17*, which is known to be expressed in fetal HSCs and maintain stem cell potency ([@bib25]), is highly expressed, as is *Il6st*, which is part of the receptor complex for hematopoietic and stem cell factors interleukin (IL)-6, leukemia inhibitory factor (LIF), and Oncostatin M ([@bib45]). Also, *Nos3* (endothelial nitric oxide synthetase), which functions in AGM HSC and HP/SC generation ([@bib50]), is highly expressed. *VEGF-R*, *Flt1*, and *Kdr* are expressed along with other HSC genes such as *Cdkn1c*, *Pdzk1ip1*, *Procr*, *Ramp2*, *Trim47*, and *Vwf.* Thus, the near-equivalence of the transcriptomic profiles of the 8 *Ly6a*^+^CD27^med^ ICGS2 cells provides a likely genetic identity for the first cells achieving HSC function in the mouse embryo.

Functional HSCs Are Localized in 1- to 2-Cell IAHCs {#sec2.6}
---------------------------------------------------

Having defined the transcriptome of functional HSCs, we examined the localization of CD27-, Ly6a-, and Gata2-expressing cells within IAHCs. E11 *G2V* cryosections immunostained for CD27 and CD34 showed rare G2^+^CD34^+^CD27^+^ cells almost exclusively within the smallest ventrally located IAHCs. [Figure 6](#fig6){ref-type="fig"}A shows two CD34^+^G2^+^CD27^+^ cells (arrowhead) attached to one CD34^+^G2^+^CD27^−^ cell within the endothelium, and a single rounded/bulging CD34^+^G2^+^CD27^+^ cell (arrow). Another section shows a ventral cluster ([Figure 6](#fig6){ref-type="fig"}Bi) with two CD34^+^G2^med^CD27^+^ cells (one appearing to be bulging out of the endothelium) surrounded by 3--4 CD34^+^G2^+^CD27^−^ cells. Also found ventrally ([Figure 6](#fig6){ref-type="fig"}Bii) was a 2-cell cluster with a single CD34^+^G2^med^CD27^+^ cell closely associated with a CD34^+^G2^lo^CD27^−^ cell ([Video S1](#mmc3){ref-type="supplementary-material"}). [Figure 6](#fig6){ref-type="fig"}Biii shows a single rounded bulging CD34^+^G2^+^CD27^+^ cell on the dorsal aspect of the aorta (likely an HPC; [@bib69]). Examination of CD27^+^ cell-containing IAHCs revealed that 80% (56 out of 70; 42 in 1-cell clusters and 14 in 2-cell clusters; n = 4 embryos) were 1- to 2-cell clusters ([Figure S6](#mmc1){ref-type="supplementary-material"}). Since all HSCs and most multipotent progenitors are CD27^+^, we conclude that these functional cells are localized closely to the ventral aortic endothelium within small or single-cell IAHCs.Figure 6Functional HSCs Are Localized in 1- to 2-Cell IAHC Cells(A--D) Sections through dorsal aorta of E11 (43 somite pairs, sp) *Gata2Venus* (green in A and B) and *Ly6aGFP* (green in C) and of E10.5 (36sp) *Csf1rGFP* (MacGreen; green in D) embryos. Nuclei are indicated in blue (DAPI), endothelial and IAHC cells are indicated in red (CD34) and CD27^+^ cells are indicated in white. v, ventral, d, dorsal.(A) Arrowhead indicates small cluster containing two G2^+^CD27^+^ cells attached to one G2^+^CD27^−^ cell. Arrow indicates a single rounded/bulging G2^+^CD27^+^ cell.(B) In (Bi), ventral cluster with two G2^med^CD27^+^ cells (one bulging out of endothelium). (Bii) Ventral two-cell cluster (G2^med^CD27^+^ and G2^lo^CD27^−^ cells). (Biii) Single rounded bulging G2^+^CD27^+^ cell on dorsal side of aorta.(C) In (Ci), single Ly6aGFP^+^CD27^+^ cell (arrowhead) at apex of bulging Ly6aGFP^+^ cell within ventral endothelium. A neighboring GFP^+^ cell in the ventral endothelium is CD27^−^ (arrow). (Cii) Two round CD27^+^ cells (one is Ly6aGFP^lo^, indicated by arrowhead) adjacent to each other and attached to interspersed Ly6aGFP^+^ endothelium. (Ciii) Three CD27^+^ cells (indicated by arrowheads; one is Ly6aGFP^+^) in very close association with ventral endothelium. White dashed boxes indicate magnified areas.(D) One CD27^+^CD34^+^ cell on dorsal endothelial wall closely associated with a macrophage. White dashed box indicates area for which MacGreen and CD27 expression is shown.Scale bars, 20 μm.

Video S1Three-Dimensional Video Showing a Ventral Two-Cell Cluster with One G2^med^CD27^+^ Cell and One G2^lo^CD27^−^ Cell, Related to Figure 6Bii *Gata2Venus* (green), nuclei in blue (DAPI), endothelial and IAHCs in red (CD34) and CD27^+^ cells in white.

E11 *Ly6aGFP* transgenic embryo sections were also immunostained to examine whether this HSC marker could subset and/or provide further validation into the localization of CD27^+^ HSCs. A single GFP^+^CD27^+^ cell was observed at the apex of a bulging GFP^+^ cell within the ventral endothelium ([Figure 6](#fig6){ref-type="fig"}Ci, arrowhead); another GFP^+^ cell (arrow) was observed in the ventral endothelium, but it was CD27^−^. [Figure 6](#fig6){ref-type="fig"}Cii indicates two round adjacent CD27^+^ cells, of which one is GFP^lo^ (arrowhead) and attached to interspersed GFP^+^ endothelial cells. Three CD27^+^ cells, one of which is GFP^+^ ([Figure 6](#fig6){ref-type="fig"}Ciii, arrowheads), were found in very close association with the ventral endothelium. The juxtaposition of single CD27^+^Ly6aGFP^+^ cells to the ventral aortic endothelium indicates that HSCs emerge directly from embryonic endothelium as single cells within intra-aortic clusters of 1--2 cells.

Discussion {#sec3}
==========

Here, we identified the transcriptome of the first functional adult repopulating HSCs. Starting from Gata2-based single-cell index-sorting and iterative single-cell analyses, the "inner" HSC transcriptional regulatory network is connected directly with multipotent hematopoietic function *in vivo* and *in vitro*. Specific levels of Gata2, cKit, and CD27 expression define all functional *in vivo* repopulating HSCs, and, together with Ly6aGFP expression, CD27 localizes the first HSC to the smallest intra-aortic clusters of 1--2 cells. The surprising variability in gene expression levels within highly enriched single cells suggests that establishment of hematopoietic function is stochastic, occurring through dynamic regulation and/or unstable expression of groups of pivotal genes.

Emerging HCs Are Heterogeneous in Phenotype, Transcriptome, and Function {#sec3.1}
------------------------------------------------------------------------

EHT occurs during a short 2- to 3-day period during mouse midgestation ([@bib79], [@bib81]) and extends over the length of the aorta to produce IAHCs that are predominantly ventral ([@bib52], [@bib65], [@bib69]) and more abundant near the juncture of the vitelline artery ([@bib41]). Individual intra-aortic clusters range from 1 to 19 cells at E10.5 and from 1 to 11 cells at E11.5 ([@bib79]). Single-cell quantitation of functional HPCs and HSCs within the clusters shows that the number of lineage-restricted HPCs is the highest, followed by that of multipotent HPCs and rare HSCs. This low frequency of HSCs implies that stem cell identity/function is a difficult hematopoietic fate to achieve.

Whereas all functional HSCs are in ventral clusters and near the vitelline junction, it cannot be predicted which emerging cell in the aorta is an HSC. The variability in phenotypic marker expression, and the degree of heterogeneity found in the transcriptomes of individual cells during the embryonic development of HPCs, pre-HSCs, and HSCs ([@bib80]), has precluded the identification of the transcriptome of rare HSCs. Rather than dependence on surface molecules not required for HSC function, Gata2-based index-sorting more directly connected with the "inner" hematopoietic regulatory network. G2^med^CD31^hi^cKit^hi^ cells highly enriched in multipotent HPCs and containing all functional repopulating HSCs show unexpected heterogeneity between single-cell transcriptomic profiles. Louvain analysis of \>1,000 sequenced cells revealed 5 major cell clusters. Unexpectedly, within this highly enriched set of IAHC cells, one major cluster still expressed endothelial markers and was deemed endothelial-like (an EC). Surprisingly, it did not express *Runx1*. The second major cluster exhibited a hematopoietic gene-expression profile, and other minor clusters showed mixed or mature HC profiles.

Considering that the G2^med^CD31^hi^cKit^hi^ fraction contains a high frequency of multipotent HPC and HSC activity, it begs the question whether the EC and/or the other minor cell clusters possess some degree of hematopoietic identity but either are not yet functional or are the predecessors of HPCs and HSCs. Data from several laboratories have described embryonic HCs lacking HSC activity and have shown that these cells can exhibit HSC function after *in vitro* culturing ([@bib21], [@bib60]) or neonatal transplantation ([@bib78]), perhaps by stabilization of a genetic program. While some of these cells could represent pre-HSCs, others could be products of EHT that never successfully achieve HSC function. They may be in a "neutral" or "naive" state awaiting establishment of another functional hematopoietic identity, perhaps to a multipotent progenitor that others have shown to maintain steady-state hematopoiesis ([@bib10], [@bib53], [@bib59], [@bib63], [@bib67]).

Heptad Factors and Gata2 Heterogeneous Expression {#sec3.2}
-------------------------------------------------

We discovered variability in the expression levels of the hematopoietic heptad TFs in the clusters. The requirements for *Gata2*, *Runx1*, and other heptad TFs *Lmo2*, *Fli1/Erg*, and *Tal/Lyl1* in EHT and HSC generation ([@bib12], [@bib16]) have been extensively demonstrated in the mouse embryo ([@bib18]). The TFs work in a combinatorial manner to activate transcription of downstream hematopoietic effector genes ([@bib56], [@bib76]). Whereas the single haploinsufficient state of *Gata2* and *Runx1* affects HC development, the double haploinsufficiency of these TFs has more profound effects ([@bib76]), indicating the exquisite sensitivity of hematopoietic development to combinatorial TF levels.

The fact that, within the highly enriched IAHC fraction, the EC was negative for *Runx1* expression and UC1 was negative for *Gata2* expression indicates that TF level changes may result in non-functional HCs. However, it is important to note that *Runx1*- and *Gata2*-deleted embryos still produce some functional HCs ([@bib29], [@bib72], [@bib74]), suggesting that there is more than one way to make a HC. The absence of complex definitive hematopoietic activity in such embryos confirms the pivotal role of these TFs in the generation of functional HSCs.

When linked to the recently demonstrated pulsatile expression of Gata2 in cells undergoing EHT ([@bib19]), a dynamic combinatorial TF code may affect hematopoietic fate and function acquisition in individual cells. For example asynchronous fluctuations of levels of several TFs (due to transcriptional pulsing, protein processing, and/or half-life) could result in a variety of different molecular states, as shown in T cells ([@bib32]). Only when a sweet spot of combinatorial factor levels is reached within a single cell will HSC or HPC identity and function be achieved. This would be consistent with the low frequency of HSCs (1--2 HSCs/\~700 cluster cells) and the higher frequency of HPCs (350/\~700) found in the *in vivo* E10.5 aorta at the time of embryo isolation. It also could explain why the simple combined transduction and overexpression of TFs in reprogramming experiments does not robustly induce the transition to HSC fate ([@bib17]).

Novel Combinations of Iterative Single-Cell Methods Identify the HSC Transcriptome {#sec3.3}
----------------------------------------------------------------------------------

Iterative single-cell RNA-seq, index-sorting, functional analyses, and bioinformatics led us to progressively higher enrichments of HSCs. Several putative HSC markers were identified within the HC1 single-cell transcriptomes and included *CD27*, *Selp*/*P-selectin*, and *Mpl*. Expression level distribution of single cells in Louvain clusters indicated that CD27 and Selp were likely to be most useful. Previously, CD27 was reported to be expressed on bone marrow ([@bib73]) and AGM HSCs ([@bib36]). Although CD27 is not exclusive to HSCs (and is expressed by some cells in the EC Louvain cluster), we discovered that cells expressing specific medium levels of CD27 within the G2^med^SSC^lo^CD31^hi^cKit^hi^ fraction yielded a further 6.5-fold enrichment on top of the HC1-only enrichment. While multipotent/bipotent HPCs were also enriched in this CD27^med^ fraction, all unipotent HPCs were absent. As *Selp* is most prominently expressed by HC1 cells, it also could offer an opportunity for further enrichment of aortic HSCs ([@bib66]). Finally, Mpl, the receptor for thrombopoietin is known to regulate the generation and self-renewal of AGM HSCs ([@bib54]). Together, these markers offer additional opportunities for the isolation/identification of single functional HSCs as they are first generated in the embryo.

Stratifications of single-cell transcriptomic data revealed the expression of a combination of other genes expressed by functional HSCs. These include *Ly6a*, *DLL4*, *Sox17*, and *eNOS*, as well as others. Ly6aGFP has been shown to be expressed on all AGM HSCs ([@bib15], [@bib64]); DLL4 is involved in arterial endothelial identity and, most recently, has been shown to govern the dynamics of cluster formation and HSC production ([@bib8], [@bib20], [@bib57]); Sox17 maintains stem cell potency ([@bib25]); and the deficiency of eNOS affects the development of IAHCs and functional HSCs ([@bib50]). The fact that the combined expression of these genes occurs in the 8 cells within the 119 sequenced G2^med^SSC^lo^CD31^hi^cKit^hi^CD27^+N^ single cells (isolated from 6 embryos) has important implications for understanding the regulation of HSC fate/function establishment and provides a useful reference for the *ex vivo* generation and/or growth of HSCs.

Emerging Functional HSCs Are Localized in 1- to 2-Cell Ventral Aortic Clusters {#sec3.4}
------------------------------------------------------------------------------

Since HSC fate acquisition is rare, there has been much speculation on the specific localization of HSCs within the IAHCs. Do they take on HSC fate immediately upon emergence from the hemogenic endothelium, or do they emerge as pre-HSCs? Do they emerge as a single cell and remain as a 1-cell cluster, or are they within larger clusters of proliferative cells?

Time-lapse imaging of the zebrafish and mouse embryonic aorta proved that the AGM region is a HC-generative niche ([@bib5], [@bib7], [@bib31]). Single HCs emerge directly from ventral aortic endothelial cells, and results of genetic studies support that at least some of the cells taking on hematopoietic identity are functional HSCs. Here, by co-expression of CD27 and Ly6aGFP, we show the localization of HSCs to the small 1- to 2-cell aortic clusters. Additionally, our RNA-seq data show DLL4 expression in the single HSC profiles, whereas the other single G2^med^SSC^lo^CD31^hi^cKit^hi^CD27^+N^ aortic cells are DLL4 negative/low. These results are in agreement with a recent study showing that, in the absence of DLL4, larger and more abundant aortic clusters are established ([@bib57]), and, together, they suggest that DLL4 may be maintaining HSC quiescence and/or function.

Finally, we observed single MacGreen^+^ macrophages interacting with single aortic CD27^+^ ([Figure 6](#fig6){ref-type="fig"}D) and Ly6a^+^ emerging cells ([@bib40]). The presence of these macrophages in the AGM enhances HSC and HPC output ([@bib40]) and further reinforces the notion that intersecting multiple signals are needed for establishing HSC fate identity and function in single emerging cells. In conclusion, the iterative approaches used in our study have enabled the correspondence of single-cell transcriptomic profiles with the first functional HSCs generated in mouse.

STAR★Methods {#sec4}
============

Key Resources Table {#sec4.1}
-------------------

REAGENT or RESOURCESOURCEIDENTIFIER**Antibodies**Rat anti-Mouse CD31-BV605 (clone 390)BioLegendCat\# 102427; RRID:[AB_2563982](nif-antibody:AB_2563982){#intref0010}Rat anti-Mouse CD117-BV421 (c-Kit) (clone 2B8)BD BiosciencesCat\#562609; RRID:[AB_11154585](nif-antibody:AB_11154585){#intref0015}Armenian hamster anti-Mouse CD27-APC (clone LG.7F9)eBioscience/Thermo Fisher ScientificCat\# 17-0271-82; RRID: [AB_469370](nif-antibody:AB_469370){#intref0020}Rat anti-Mouse CD34-biotin (clone RAM34)eBioscience/Thermo Fisher ScientificCat\# 13-0341-82; RRID: [AB_466425](nif-antibody:AB_466425){#intref0025}Rabbit anti-GFPMBL InternationalCat\# 598; RRID: [AB_591819](nif-antibody:AB_591819){#intref0030}Armenian hamster anti-Mouse CD27 (clone LG.7F9)eBioscience/Thermo Fisher ScientificCat\# 14-0271-82; RRID: [AB_467183](nif-antibody:AB_467183){#intref0035}Streptavidin-Alexa Fluor 555Invitrogen/Thermo Fisher ScientificCat\# s21381; RRID: [AB_2307336](nif-antibody:AB_2307336){#intref0040}Goat anti-Rabbit IgG (H+L)-Alexa Fluor 488Invitrogen/Thermo Fisher ScientificCat\# A-11008; RRID: [AB_143165](nif-antibody:AB_143165){#intref0045}Goat anti-Armenian hamster IgG-Alexa Fluor 647 (clone Poly4055)BioLegendCat\# 405510, RRID:[AB_2566695](nif-antibody:AB_2566695){#intref0050}APC anti-Mouse CD45.1 (clone A20)BD BiosciencesCat\#558701; RRID:[AB_1645214](nif-antibody:AB_1645214){#intref0055}PE anti-Mouse CD45.2 (clone 104)BD BiosciencesCat\#560695; RRID:[AB_1727493](nif-antibody:AB_1727493){#intref0060}**Chemicals, Peptides, and Recombinant Proteins**Collagenase Type I from *Clostridium histolyticum*Sigma-AldrichCat\#C0130; Lot\#02M1425VFoetal Bovine Serum Standard QualityBrunschwig Chemie BVCat\#BS01500; Lot\#212-22365010% Triton X-100Sigma-AldrichCat\#93443-100 mlSUPERase-In RNase InhibitorAmbionCat\#AM2694dNTP mixThermoFisherCat\#10319879ERCC RNA Spike-In MixThermoFisherCat\#4456740Superscript II Reverse TranscriptaseThermoFisherCat\#18064-014BetaineSigma-AlrichCat\#B0300Magnesium chlorideThermoFisherCat\#AM9530GKAPA HiFi Hotstart ReadyMixKAPA BiosystemsCat\#KK2601Agencourt AMPure XP beadsBeckman CoulterCat\#A63881EB solutionQIAGENCat\#19086**Critical Commercial Assays**High-sensitivity DNA chipAgilentCat\#5067-4626Quant-iT Picogreen double stranded DNA assay kitThermoFisherCat\#P7589Nextera XT DNA sample preparation kit 96 samplesIlluminaCat\#FC-131-1096Nextera XT 96-Index kit, 384 samplesIlluminaCat\#FC-131-1002KAPA qPCR quantification kitKAPA BiosystemsCat\# KK4824**Deposited Data**Single-cell RNaseqThis paperAccession number: [GSE143637](ncbi-geo:GSE143637){#intref0065}**Experimental Models: Organisms/Strains**Mouse: Gata2VenusLaboratory of Elaine Dzierzak; [@bib29], BloodN/AMouse: B6.Cg-Tg(Ly6a-EGFP)G5Dzk/JThe Jackson Laboratory<https://www.jax.org/strain/012643>Mouse: B6.Cg-Tg(Csf1r-EGFP)1Hume/J (also known as MacGreen)The Jackson Laboratory<https://www.jax.org/strain/018549>Mouse: B6.SJL-*Ptprc*^*a*^*Pepc*^*b*^/BoyCrl (also known as Ly5.1)Charles RiverStrain code: 494 <https://www.criver.com/products-services/find-model/ly51-mouse?region=3671>Mouse: C57BL/6JOlaHsdEnvigoOrder code: 057 <https://www.envigo.com/products-services/research-models-services/models/research-models/mice/inbred/c57bl-6-inbred-mice/c57bl-6jolahsd/u.k.aspx>**Oligonucleotides**TSO: AAGCAGTGGTATCAACG\
CAGAGTACATrGrG+G-3′[@bib55]N/AOligo-dT30VN: AAGCAGTGGTATCA\
ACGCAGAGTAC(T30)VN-3′[@bib55]N/AISPCR: AAGCAGTGGTATCAACG\
CAGAGT[@bib55]N/A**Software and Algorithms**Prism Version 7GraphPad<http://www.graphpad.com/scientific-software/prism>BD Facs Diva version 8BD Biosciences<http://www.bdbiosciences.com/en-us>FlowJo Version 10.1r5Tree Star, Inc<https://www.flowjo.com/solutions/flowjo/downloads/previous-versions>GSNAP[@bib77]<http://research-pub.gene.com/gmap/>HTSeq[@bib2]<https://htseq.readthedocs.io/en/release_0.11.1/install.html>PCA[@bib82]prcomp in R stats packageSelection of Highly Variable Genes[@bib9]<https://static-content.springer.com/esm/art%3A10.1038%2Fnmeth.2645/MediaObjects/41592_2013_BFnmeth2645_MOESM313_ESM.pdf>ICGS[@bib51]<https://altanalyze.readthedocs.io/en/latest/ICGS/>DESeq2[@bib39]<http://bioconductor.org/packages/release/bioc/html/DESeq2.html>SPRING[@bib75]<https://github.com/AllonKleinLab/SPRING>hscScore[@bib24]<https://github.com/fionahamey/hscScore>**Other**Interactive websiteThis paper<https://gottgens-lab.stemcells.cam.ac.uk/DZIERZAK/>Single-cell RNaseq[@bib80]Accession number: [GSE67120](ncbi-geo:GSE67120){#intref0145}

Resource Availability {#sec4.2}
---------------------

### Lead Contact {#sec4.2.1}

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Elaine Dzierzak (<Elaine.Dzierzak@ed.ac.uk>).

### Materials Availability {#sec4.2.2}

This study did not generate new unique reagents.

### Data and Code Availability {#sec4.2.3}

The single-cell RNA sequencing data generated in this study have been deposited in GEO (<https://www.ncbi.nlm.nih.gov/geo/>) with accession number: [GSE143637](ncbi-geo:GSE143637){#intref0160}. The code used is available on request. An interactive website containing the single-cell RNASeq results is available at <https://gottgens-lab.stemcells.cam.ac.uk/DZIERZAK/>.

Our datasets were examined in the context of a published single cell dataset ([@bib80]) which can be found in GEO under accession number: [GSE67120](ncbi-geo:GSE67120){#intref0170}.

Experimental Model and Subject Details {#sec4.3}
--------------------------------------

### Mouse models {#sec4.3.1}

All mice were housed and bred in animal facilities at the University of Edinburgh, in compliance with UK Home Office regulations. All animal experiments were conducted according to a UK Home Office Project License (PPL 70/8076 and continuation PC6D479E0) and approved by the University of Edinburgh Ethical Review Committee.

Adult C57BL/6JOlaHsd (Ly5.2) wild-type females were obtained from Envigo (order code: 057) and used at 2-4 months old. *Gata2*^*V/V*^ ([@bib29]), *Ly6aGFP*^*+/−*^ ([@bib15]) and *Csf1rGFP*^*+/−*^ (MacGreen, ([@bib62]) males (\> 10 backcrosses onto C57BL/6JOlaHsd) were used at 2-12 months old.

All transplantations were with 2-4 months old B6.SJL-*Ptprc*^*a*^*Pepc*^*b*^/BoyCrl (Ly5.1/5.1; Charles River; strain code: 494) recipients (males and females mixed).

Method Details {#sec4.4}
--------------

### Mouse embryo generation {#sec4.4.1}

*Gata2*^*V/+*^, *Ly6aGFP*^*+/−*^ and *Csf1rGFP*^*+/−*^ embryos were generated by timed matings of C57BL/6JOlaHsd wild-type females with *Gata2*^*V/V*^, *Ly6aGFP*^*+/−*^ and *Csf1rGFP*^*+/−*^ males respectively. Genotyping was performed by Venus or GFP fluorescence screening of the placenta or embryonic tail. Day of plug discovery was embryonic day (E)0 and staging was by somite pair (sp) counts (E10 = 30-39sp; E11 = 40-49sp).

### Preparation of AGM single cell suspensions for flow cytometry {#sec4.4.2}

AGM (aorta-gonad-mesonephros) regions (including trunk portion of the vitelline and umbilical arteries) of E10/11 embryos were dissected as previously described ([@bib44]). Single cell suspensions were prepared by enzymatically digesting tissues at 37°C in 0.125% type 1 collagenase (C0130, Sigma-Aldrich) for 45 min, after which tissues were further mechanically disrupted with a P1000 pipette. Cells were subsequently passed over a 0.35 μm strainer, collagenase washed away with PBS+10%FBS+1%P/S (PFP), spun down (234*g*) and resuspended in PFP for flow cytometric antibody staining. Cells were incubated at 4°C for 30 min in PFP with directly conjugated antibodies against CD31 (CD31-BV605, 1:100, cat\# 102427, Biolegend), cKit (cKit-BV421, 1:200, cat.\# 562609, BD) and CD27 (CD27-APC, 1:75, cat.\# 17-0271-82. eBioscience). Excess of antibodies was washed away with PFP before fluorescence activated cell sorting (FACS) on an AriaII (BD). Dead cell exclusion was by Hoechst 33342 and gates were set based on unstained WT and fluorescence-minus-one (FMO) controls. Sorted single cells were collected in 50% FBS/PBS for functional analyses (transplantation + bulk CFU-C assay). Both collagenase and FCS were batch tested for optimal AGM conditions.

### Hematopoietic stem cell transplantation and (single-cell) CFU-C assay {#sec4.4.3}

For transplantation, sorted cell populations (Ly5.2/CD45.2 background) were resuspended in PBS together with 2x10^5^ Ly5.1 spleen carrier cells and intravenously injected into irradiated Ly5.1 (CD45.1) recipients that had received two split-doses of 4.5 Gy (Cs-137 Ɣ-irradiator). Peripheral blood was sampled for CD45.1- and CD45.2 flow cytometric analysis at 4 and 16 weeks post-transplantation. Mice were considered repopulated with long-term reconstituting cells at ≥ 5% donor chimerism. For population/bulk CFU-C assays, sorted cells were resuspended and cultured in Methylcellullose medium (M3434; Stem Cell Technologies) in a humidified chamber at 37°C and 5% CO~2~ for 9-11 days after which colonies were counted. For single-cell CFU-C assays, cells were sorted directly into 96-well plates with one (P1000) drop of Methylcellulose medium deposited per well and cultured and counted under the same conditions as for population CFU-C assays.

### Immunohistochemistry on cryosections {#sec4.4.4}

*Gata2*^*V/+*^ and *Ly6aGFP*^*+/−*^ and MacGreen^+/−^ embryos were staged and fixed in 2% PFA/PBS for 1 hr and quickly washed in PBS. Embryos were then equilibrated overnight (O/N) in 20% sucrose/PBS at 4°C, after which they were washed in Tissue-Tek O.C.T. embedding matrix (Sakura). Tissue paper was used to remove remaining sucrose and each embryo was placed in an individual mold filled with embedding matrix. Forelimbs were orientated exactly above hind limbs before being frozen on dry ice in absolute ethanol. 10 μm transversal cryosections were cut through the AGM region and collected on Superfrost Plus slides (Thermo Fisher Scientific). For immunohistochemistry, sections were fixed for 10 mins with acetone, washed three times with 0.05% Tween20/PBS (PBST) and then blocked with a 1:1 mixture of Streptavidin solution (Vector Laboratories Inc) and PBSblock (0.05% Tween20, 1% bovine serum albumin/PBS) for 15 mins. After three PBST washes, slides were incubated with Biotin solution (Vector Laboratories Inc) for 15 mins and washed another three times in PBST. Sections were incubated with rat anti-mouse-CD34-biotin (1:100, 13-0341-82, eBioscience), rabbit anti-GFP (1:1000, 598, MBL) and Armenian hamster anti-mouse-CD27 (1:100, 14-0271-82, eBioscience) diluted in PBSblock for 1hr at RT. Unbound primary antibodies were washed away with PBST after which sections were incubated with Streptavidin-AlexaFluor555 (1:500, S21381, Invitrogen), anti-rabbit AlexaFluor488 (1:500, A11008, Invitrogen) and anti-Armenian hamster AlexaFluor647 (1:500, 405510, Biolegend) diluted in PBSblock for 30 mins at RT. Slides were washed three times in PBST and incubated in DAPI (1:1000) diluted in PBSblock for 10 mins at RT. Afterward, slides were washed once in PBST and then mounted with SlowFade Diamond Anti-Fade Mountant (Invitrogen, Thermo Fisher Scientific). Sections were imaged with a Leica SP8 confocal microscope and images and videos generated with the LAS X software (Leica).

### Single-cell RNA sequencing {#sec4.4.5}

Cells were sorted in 2.3 μl of lysis buffer containing 0.2% Triton X-100 (Sigma-Aldrich) and 1U of Superase-In RNase Inhibitor (Ambion) and processed following the Smart-Seq2 protocol ([@bib55]) Following preamplification, all samples were purified using Ampure XP beads (Beckman Coulter) at a ratio of 1:0.6. The cDNA was then quantified using the Quant-iT PicoGreen dsDNA Assay Kit (Thermo Fisher) and size distributions were checked on high-sensitivity DNA chips (Agilent Bioanalyzer). Samples were used to construct Nextera XT libraries (Illumina) from 125 pg of preamplified cDNA. Libraries were purified and size selected (0.5X-0.7X) using Ampure XP beads. Then, libraries were quantified using KAPA qPCR quantification kit (KAPA Biosystems), pooled and sequenced in an Illumina HiSeq 4000 instrument.

### Bioinformatic Analysis {#sec4.4.6}

Reads were mapped to a custom reference index that included the *Mus musculus* genome (EMSEMBL GRCm38.p4 Release 81) and the sequences of ERCC spike-ins (Life Technologies), IRES and *Venus* using GSNAP (version 2014-10-07) ([@bib77]) with parameters: -A sam --B 5 --t 24 --n 1 --Q --N 1. HTseq-count was used to count reads mapped to each gene with parameters: --s no ([@bib2]). For further analyses, we only retained samples that had: (1) more than 100,000 reads mapped to nuclear mRNAs; (2) a proportion of reads mapped to genes (nuclear + mitochondrial) relative to total reads above 30%; and (3) less than 20% of mapped reads allocated to mitochondrial genes. Overall, 47 cells (4.1% of total) failed the QC under those criteria and 1087 cells were kept for further analysis distributed as follows: 87 E10 CD31^+^cKit^hi^G2^int^ cells, 409 E11 CD31^+^cKit^hi^G2^int^ cells, 472 E11 CD31^+^cKit^hi^G2^lo^ cells and 119 E11 CD31^hi^SSC^lo^cKit^hi^G2^med^CD27^+N^ cells. The mean of nuclear reads mapped per cell was 1,213,237. Data were normalized for sequencing depth and RNA quantity using size factors calculated on endogenous genes ([@bib9]). Highly variable genes were identified as previously described ([@bib9]), using a false discovery rate threshold equal to 0.1. Only highly variable genes were considered to perform PCA analysis, using the *prcomp* function in R. SPRING visualization ([@bib75]) and was obtained using the top 90 principal components and the 4 nearest neighbors. Clusters were defined using the *cluster_louvain* function in *R igraph* package. Violinplots were obtained using the *ggplot2* package in R. hscScores were calculated as previously described ([@bib24]). Differential expression analysis was performed using DESeq2 ([@bib39]).

CD27^+^ cells (Protein level) was extracted from HSC clusters (clusters L2.7 and L2.8). In total, there are 85 cells, with 4445 highly variable genes selected. Highly variable genes were used for ICGS clustering (AltAnalyzer ([@bib51])) with 'stringent' with cell cycle and all other parameters as default.

For integration with previously published dataset ([@bib80]), the data was downloaded from GEO repository (GSE67120) and processed as indicated above. Differential expression analysis was performed between either endothelial cells or pre-HSCs (including T1 and T2) or HSCs (including E12 and E14) and the remaining cells to obtain cell type specific genes using DESeq2. Only genes with log2 fold change \> 2, adjusted p value (BH method) \< 0.1 and base mean \> 50 were used for further analysis. Only the top 30 upregulated genes were selected to use in the heatmap.

Quantification and Statistical Analysis {#sec4.5}
---------------------------------------

All graphs were generated using GraphPad Prism 7. We performed Bartlett's test for homogeneity of variances to ensure variances for all samples were equal. With the assumption of normality, the data were compared for the same means using one-way ANOVA, followed by a pairwise comparison using a Student's t test, and Bonferroni correction. Significance was determined as p \< 0.05. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. FACS percentages, averages (mean; red horizontal lines in [Figures 1](#fig1){ref-type="fig"}C, 1D, [3](#fig3){ref-type="fig"}E, and [4](#fig4){ref-type="fig"}E) and error bars are ± standard error of the mean (SEM). Further statistical details of experiments can be found in the figure legends. The number of biological replicates is indicated with 'n'.
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